
Flyte, a subsidiary of VTAK, will feature its Cirrus Vision Jet fleet on Blade's platform, expanding distribution for regional air mobility.
Flyte, the regional air mobility subsidiary of Catheter Precision (NYSE American: VTAK), will feature its Cirrus Vision Jet fleet on Blade Urban Air Mobility's platform under a strategic partnership announced Tuesday. The deal puts Flyte's charter offerings in front of Blade's existing customer base, which the companies said includes premium, time-sensitive regional travelers.
The partnership is non-exclusive and covers Flyte's fleet of Vision Jets, which are equipped with the Cirrus Airframe Parachute System and Safe Return Autoland. Blade passengers will be able to book Flyte flights through Blade's platform, expanding the subsidiary's distribution without adding marketing spend. Flyte said the arrangement is expected to increase aircraft utilization and brand awareness among a targeted audience of aviation consumers already using technology-enabled air mobility services.
Blade operates a helicopter passenger service in the U.S. and Europe with an asset-light model that it plans to extend to electric vertical aircraft. Flyte, which runs its flight operations through FAA Part 135 carrier Ponderosa Air, has been building a regional air mobility platform through fleet expansion and partnerships. The Cirrus Vision Jet competes in the very light jet segment, a market that has grown as travelers seek alternatives to commercial airlines for short-haul trips.
Catheter Precision, a medical device company focused on cardiac arrhythmia treatments, acquired Flyte in 2024 as part of a pivot toward aviation. The company now trades under the VTAK ticker on the NYSE American. The partnership with Blade is the latest step in Flyte's strategy to scale its platform through established industry networks.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.